Brazil on Thursday (local time) said that it has begun preparations to bring two million doses of coronavirus vaccine from India.
In a statement, Brazil's health ministry said: "The Brazilian government informs that preparations to bring the two million doses of the vaccine against Covid-19 from India are already underway."
"The Azul airlines flight will be anticipated and will leave Viracopos Airport, in Campinas (SP), at 1.00 pm this Thursday (14t) for Recife (PE), from where it will depart directly to the Indian city of Mumbai. The vaccines are scheduled to arrive in Brazil next Saturday (16) at Galeao Airport (RJ)," it said.
The Ministry further said that the Airbus A330neo will be equipped with specific containers to ensure temperature control of the doses in accordance with the manufacturer's recommendations.
The doses have been produced by Indian laboratory Serum Institute of India.
"The Ministry of Foreign Affairs, through the Embassy in New Delhi, has made arrangements with the Indian authorities and the Serum Institute of India, following up on a letter from President Jair Bolsonaro to Prime Minister Narendra Modi, dated January 8, and is providing assistance regarding international travel issues and procedures. The Ministry of Defense will contribute to the security of land transportation to the states," the Ministry said.
It further said that the AstraZeneca/Oxford vaccine will be distributed to the Brazilian states within five days after the approval of the National Health Surveillance Agency (Anvisa). "Immunization all over the country will be carried out simultaneously and free of charge," it added.
Speaking on the India-Brazil relations, the Ministry said, "The successful acquisition of doses from the British parent company and the Indian vaccine producer demonstrates the excellent state of Brazil-United Kingdom and Brazil-India relations and the strength of the strategic relationships we have with both countries.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU